Stay updated with breaking news from Pfizer drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Merck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30% in a clinical trial of high-risk individuals early in the course of the illness. The agency authorized the oral drug for the treatment of mild-to-moderate COVID-19 in adults who are at risk for severe disease. ....
Worries. should we even think about a second booster for health care providers and i think all of this needs to be put on the table. remember, we don t have the pfizer drug, paxlovid and won t have an omicron-specific booster so we have to deal with the cards that we re dealt with. right. and maybe a second booster is in the cards. i think it s so important to put everything out there, to bes a transparent as possible. information is power, and yet a lot of americans are just so tired of all of this, right? many have done everything you tell them to do. they have got their three shots. they have been wearing masks but now they hear of more shutdowns, more restrictions. we ve been told we re beyond the point of snuffing out covid entirely, right? y with ear going have to live with it, so the question is how can we get there, to live with it and still have a sense of normalcy? well, again, i think we have to max out our ability to ....
Who got that treatment in time soon after infections, the merck antiviral pill provides a 50% reduction in hospitalization and, at the fda is looking at that night, the uk has already proved it. but now the new candidate has come along which is what president biden was bragging about today, it s a new drug, this one from pfizer, and this one shows almost 90% effectiveness at least in this key clinical trial that they have released the data from, it brought down the chance of being hospitalized or killed by this thing by 89%. now, the devils in the details, of course. you have to get it quickly, the 89% reduction are for people who are at high risk of severe covid. a lot more data has to be released, it hasn t been peer reviewed yet. the devil is in the detail, the details are fascinating and the early indications are that this is very good news, honestly. joining us now is doctor vin gupta, criminal care pulmonologist he is ....
Including some of the surprising news about old drug research, and honestly, the old activism around drug that helped make this new drug possible. not a cure but it is looking like this might bring us closer than we ever thought we would get to what is effectively a cure. that is great news. on a totally different front, we got great news on the economy today and jobs. you might have seen the headlines about how the u.s. economy is roaring back job creation wars back. that s because of good news yesterday that was topped with morgan, and good news today came with an extra good news chaser. yesterday we had the unemployment claims, just a number of americans final billing for unemployment each week. the week before president biden was inaugurated the weekly unemployment rate claims were just astonishingly terrible, the last week of the job ....